Identifying Neurological Biomarkers to Aid in Major Depressive Disorder Diagnosis and Treatment
Recently, a leading pharmaceutical company used our BNA™ platform, powered by our age-matched, normative, comparative database to assess the effects of an SNRI antidepressant on… Read More »Identifying Neurological Biomarkers to Aid in Major Depressive Disorder Diagnosis and Treatment
